Littleton J
Division of Biomedical Science, Kings College, London, UK.
Addiction. 1995 Sep;90(9):1179-88. doi: 10.1046/j.1360-0443.1995.90911793.x.
Acamprosate is a relatively new drug that appears to be clinically useful in the treatment of alcohol dependence. Although it has proved effective in reducing relapse into drinking in clinical trials its exact mechanism of action is uncertain. Evidence is presented that the drug does not act in any of the conventional ways to reduce alcohol intake and it is proposed that it may be a novel kind of agent that suppresses "craving". On the basis of its known pharmacological effects in pre-clinical studies it is suggested that acamprosate may reduce craving that is associated with conditioned withdrawal. In addition to the potential therapeutic value of acamprosate, the drug may be useful because work directed toward understanding its mechanism of action may shed light on some of the fundamental processes that govern alcohol abuse and relapse in weaned alcohol dependent patients.
阿坎酸是一种相对较新的药物,在酒精依赖治疗中似乎具有临床效用。尽管在临床试验中已证明它能有效减少复饮,但它的确切作用机制尚不确定。有证据表明,该药物并非以任何传统方式来减少酒精摄入量,有人提出它可能是一种新型药物,可抑制“渴望”。基于其在临床前研究中已知的药理作用,有人认为阿坎酸可能减少与条件性戒断相关的渴望。除了阿坎酸潜在的治疗价值外,该药物可能还有用,因为针对了解其作用机制的研究可能会揭示一些控制断奶后酒精依赖患者酒精滥用和复发的基本过程。